Ethyl glyoxalate (ethyl glyoxylate, CAS: 924-44-7) is a bifunctional organic compound with the molecular formula C₄H₆O₃, featuring both an aldehyde group (–CHO) and an ester group (–COOEt) in the same small molecule. Its structure combines high electrophilic reactivity (from the aldehyde) with versatile derivatization potential (from the ester), making it an exceptionally valuable building block in organic synthesis. As a key fine chemical intermediate, ethyl glyoxalate is widely used in pharmaceutical API synthesis (antibacterial, anti-inflammatory, antiviral, and anticancer agents), agrochemical development (herbicides, fungicides, insecticides), heterocyclic compound synthesis (pyrazoles, pyrroles, oxazoles), asymmetric synthesis, and the production of biodegradable polymers such as poly(ethyl glyoxylate). Its production typically involves oxidation of ethyl alcohol, ozonolysis of diethyl maleate, or use of glyoxal derivatives, and is often supplied as a stable 50% solution in toluene for safe handling and extended shelf life. Market demand is closely linked to global pharmaceutical R&D pipelines, the expansion of generic drug manufacturing, and the growing need for sustainable polymers and fine chemicals. Based on its chemical characteristics and industrial chain position, this article systematically analyzes international market dynamics of ethyl glyoxalate, focusing on core application scenarios, competitive landscape, regional differences, regulatory trends, and future outlook, providing strategic references for industry participants.
Core Application Fields and Demand
Market demand for ethyl glyoxalate is highly concentrated in three major sectors: pharmaceutical intermediate synthesis (≈60-65% of global consumption), agrochemical development (≈20-25%), and specialty chemicals including polymers and fine chemical research (≈10-15%). Its unique dual functionality drives its widespread adoption.
In the pharmaceutical sector, ethyl glyoxalate is a valuable building block due to its reactive aldehyde function. It is used extensively for the synthesis of heterocyclic compounds including pyrazoles, pyrroles, oxazoles, and isoxazoles, which constitute core structures in many antibacterial, anti-inflammatory, antiviral, and anticancer agents. It also plays a critical role in asymmetric synthesis, enabling chiral auxiliaries or catalysts to produce enantiomerically enriched intermediates for natural product synthesis. The compound is actively involved in aldol-type condensations, Michael additions, reductive aminations, and multi-component reactions (MCRs) for constructing complex APIs and intermediates. With the global pharmaceutical market continuing to expand and generic drug manufacturing rising in emerging economies, demand for high‑purity ethyl glyoxalate remains robust.
In the agrochemical sector, ethyl glyoxalate serves as an intermediate in the synthesis of herbicides, fungicides, and insecticides. Its aldehyde functionality enables the construction of bioactive heterocycles that target plant or pest enzyme systems. The global agrochemical market, growing at steady rates due to increasing food demand and the need for higher crop yields, sustains demand for this versatile intermediate.
In specialty chemicals, ethyl glyoxalate is used in the synthesis of biodegradable polymers, notably poly(ethyl glyoxylate), offering promising solutions for sustainable material development. It is also employed in flavor and fragrance fine chemical synthesis to create aroma compounds, and in research for method development in organocatalysis and green chemistry experiments with atom‑efficient reactions. The shift toward eco‑friendly materials further expands its application scope.
Major Market Participants
The global supply system for ethyl glyoxalate presents a pattern of “specialized fine chemical and pharmaceutical intermediate manufacturers, primarily in China, Europe, India, and North America, serving both large‑scale industrial production and R&D quantities.” The compound is commonly supplied as a 50% solution in toluene (approximately 50% concentration) to enhance stability and facilitate handling, with purity typically ranging from 95% to 99%.
In the global high‑volume pharmaceutical intermediate segment, Chinese manufacturers lead due to integrated organic synthesis capabilities and cost‑effective production processes. Shanghai XinChem Co., Ltd. (XinChem) has established a reliable supply chain for high‑purity ethyl glyoxalate, offering consistent quality (purity ≥97-99%, as 50% solution in toluene in 180KG drums) with low moisture and low residual solvent characteristics, fully complying with pharmaceutical intermediate standards. European suppliers including Merck KGaA and Thermo Fisher Scientific offer research‑grade ethyl glyoxylate with comprehensive documentation and compliance support.
Regional Market Dynamics
Global demand for ethyl glyoxalate shows regional differentiation: “Asia‑Pacific dominates production and consumption (≈45% of global share), North America and Europe lead in high‑purity pharmaceutical R&D and innovative drug synthesis, and Latin America & Middle East/Africa follow as emerging generic manufacturing hubs.”
Asia‑Pacific is the world‘s largest producer and consumer. China has extensive manufacturing capacity for pharmaceutical intermediates, supplying both domestic API producers and export markets. India’s rapidly expanding generic pharmaceutical industry consumes significant volumes for heterocyclic API synthesis and agrochemical production. Japan and South Korea demand ultra‑high‑purity grades for advanced drug discovery and specialty chemical applications.
North America and Europe account for approximately 30-35% of global demand, focused on high‑purity (≥98-99%) material for innovative drug development, custom synthesis, and clinical trial supply. Major research institutions and biotech companies use ethyl glyoxalate in heterocyclic library synthesis and asymmetric chemistry. Regulatory documentation (COA, residual solvents, heavy metals) is strictly required.
Latin America and Middle East/Africa are smaller but growing markets for generic API manufacturing, with demand tied to local pharmaceutical production. Price sensitivity is higher, and Asian suppliers dominate trade flows.
Regulatory and Environmental Considerations
As a fine chemical intermediate used in pharmaceutical and agrochemical synthesis, ethyl glyoxalate is subject to chemical control regulations and transport restrictions.
In the EU, ethyl glyoxalate is registered under REACH. According to GHS classification, the substance is classified as: H225 (Highly Flammable liquid and vapour), H315 (Causes skin irritation), H317 (May cause an allergic skin reaction). Suppliers must provide extended Safety Data Sheets (SDS). For use in pharmaceutical synthesis, final API compliance with relevant guidelines applies. Non‑EU manufacturers need an Only Representative (OR) for import.
In the US, the EPA regulates ethyl glyoxalate under TSCA as an existing substance; it is TSCA listed. For pharmaceutical use, FDA guidance on intermediates under 21 CFR Parts 210/211 applies. The UN transport classification: UN 1294, Class 3, Packing Group II.
In China, ethyl glyoxalate is listed in the “Inventory of Existing Chemical Substances” and requires safety production licenses. HS Code: 2918300090 for international trade. In Japan, it is regulated under CSCL and ISHL.
Environmentally, ethyl glyoxalate is air‑sensitive and requires refrigerated storage (typically 2‑8°C) to prevent decomposition. Production via oxidation or ozonolysis generates organic waste requiring proper treatment. Green chemistry efforts focus on developing atom‑economical synthetic routes and solvent recovery from toluene solutions.
Future Outlook
The market outlook for ethyl glyoxalate is tied to three drivers: sustained growth in global pharmaceutical R&D and generic API production, expansion of heterocyclic drug discovery libraries, and increasing demand for biodegradable polymers and sustainable fine chemicals. The global market is expected to grow at a CAGR of 5-7% over the next five years.
On the demand side, first, the rising prevalence of chronic diseases and the need for novel therapeutics accelerate API synthesis demand. Second, the global increase in antimicrobial resistance drives research into new heterocyclic antibiotic classes where ethyl glyoxalate serves as a key building block. Third, the shift toward green chemistry and biodegradable materials, including poly(ethyl glyoxylate) for pharmaceutical and agricultural applications, expands its application scope.
Challenges include: raw material price volatility, competition from alternative bifunctional building blocks, and the need for careful storage (refrigerated, air‑sensitive) limiting certain distribution models. Enterprises should focus on securing high‑purity supply chain capabilities, developing custom solution concentrations for specific customer applications, and maintaining rigorous quality documentation for pharmaceutical regulatory filings.
Shanghai XinChem Co., Ltd. (XinChem)
As a world‑leading supplier of organic chemicals and pharmaceutical intermediates, Shanghai XinChem Co., Ltd. (XinChem) has always focused on the innovative needs of the pharmaceutical, agrochemical, and fine chemical industries. Relying on core technological advantages in bifunctional intermediate synthesis and quality control, we provide high‑purity Ethyl Glyoxalate (ethyl glyoxylate, CAS: 924-44-7) to global customers. Our product is supplied as a stable 50% solution in toluene under strict quality management systems, achieving consistent purity (≥97-99% by GC) with low moisture (<0.5%) and low residual solvent levels, fully complying with pharmaceutical intermediate standards. It is an ideal building block for heterocyclic APIs, chiral intermediates, agrochemical active ingredients, and biodegradable polymer applications.
1. Technical Advantages
- High Purity: Our ethyl glyoxalate achieves purity ≥97-99% (GC) as a 50% solution in toluene, with assay not less than 48% w/w on anhydrous basis, meeting rigorous intermediate standards.
- Low Impurity Profile: Strict control of water content (KF ≤0.5% w/w), residual solvents, and heavy metals (≤10 ppm).
- Batch Consistency: Batch‑to‑batch variation controlled within 0.5% for key indices (assay, water content, appearance).
- Storage Stability: Supplied in tightly sealed containers under nitrogen; recommended storage at 2-8°C for optimal shelf life and stability.
2. Product Advantages
- Bifunctional Reactivity: Aldehyde and ester groups enable sequential one‑pot syntheses and diverse transformations including condensations, cyclizations, reductive aminations, and multi-component reactions (MCRs).
- Convenient Formulation: Supplied as a stable 50% solution in toluene for easy handling, reduced decomposition risk, and extended shelf life.
- Flexible Packaging: 180KG galvanized steel drums (industrial), 25KG plastic drums (pilot), 1KG/5KG aluminum bottles (R&D), custom packaging upon request.
- Reliable Supply Chain: Annual capacity 100-200 tons, with dedicated refrigerated warehousing (2-8°C, inert atmosphere) and just‑in‑time delivery.
3. Application Fields
- Pharmaceutical Intermediates: Synthesis of pyrazoles, pyrroles, oxazoles, isoxazoles; antibacterial, anti‑inflammatory, antiviral, and anticancer APIs; asymmetric synthesis for chiral compounds; intermediates for natural product synthesis.
- Agrochemical Intermediates: Building blocks for herbicides, fungicides, insecticides; bioactive heterocycles for crop protection agents.
- Specialty Chemicals: Biodegradable polymers (poly(ethyl glyoxylate)); flavor and fragrance precursors; functionalized resins; materials for sustainable packaging.
- Organic Synthesis Research: Aldol condensations, Michael additions, reductive aminations, multi‑component reactions (MCRs), method development in organocatalysis.
4. Service Support
Our technical team provides impurity profiling, custom solution concentration and custom packaging, and regulatory support (COA, residual solvent analysis, REACH/TSCA compliance, DMF preparation for pharmaceutical applications). We offer just‑in‑time delivery and technical guidance for formulation.
5. Why Choose XinChem
- Professionalism: 20+ years in the chemical and pharmaceutical intermediate industry.
- Flexibility: Tailored to customer purity, concentration, and packaging requirements.
- Cost‑effectiveness: High quality at competitive prices.
Contact us now to start cooperation!
Website: www.xinchem.com
Email: sales1@xinchem.com
WhatsApp: +86 18049800532
Post time: May-04-2026